Alberta Investment Management Corp (AIMCo)’s Astria Therapeutics ATXS Stock Holding History

Alberta Investment Management Corp (AIMCo)’s Portfolio ATXS Stock Details ATXS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-272,750	Closed	-$3.57M	–	602
2025 Q4	$3.57M	Buy	+272,750	New	+$3.26M	0.02%	412

Alberta Investment Management Corp (AIMCo)'s ATXS Position: Q1 2026 in Review

Alberta Investment Management Corp (AIMCo) sold out of Astria Therapeutics (ATXS) in Q1 2026, closing a stake of 272,750 shares — an estimated $3.57M sold.

Alberta Investment Management Corp (AIMCo) first reported a position in ATXS in Q4 2025 and held it in 1 quarter. The position peaked at $3.57M in Q4 2025. 0 funds tracked by Wall St. Rank hold ATXS as of Q1 2026.

Alberta Investment Management Corp (AIMCo) reported no remaining Astria Therapeutics position as of Q1 2026 after selling out during the quarter.
Alberta Investment Management Corp (AIMCo) sold 272,750 Astria Therapeutics shares in Q1 2026, an estimated $3.57M.
Alberta Investment Management Corp (AIMCo) first reported a position in Astria Therapeutics in Q4 2025 and held it in 1 quarter.
Alberta Investment Management Corp (AIMCo)'s Astria Therapeutics position peaked at $3.57M in Q4 2025.
0 funds tracked by Wall St. Rank held Astria Therapeutics as of Q1 2026.

Based on Alberta Investment Management Corp (AIMCo)'s 13F filing for Q1 2026, filed 29 Apr 2026.